The Dehydroepiandrosterone 10%/Testosterone 0.5% Topical Gel is a semisolid formulation designed for transdermal delivery of two key hormones. This gel is dispensed through a pump mechanism, which ensures easy and precise dosing. The consistency of the gel allows for targeted application on the skin, promoting efficient absorption of the active ingredients.
This formulation is primarily used in the treatment of various conditions related to hormone deficiencies or imbalances. It may be prescribed for individuals with adrenal insufficiency, where dehydroepiandrosterone (DHEA) levels are low. Additionally, it can be used in men with low testosterone levels, a condition known as hypogonadism. The gel may also be beneficial for certain postmenopausal symptoms when hormone replacement therapy is indicated.
By combining DHEA and testosterone in one topical product, this gel offers a convenient approach to hormone therapy, potentially improving symptoms associated with the aforementioned disease states.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dehydroepiandrosterone (DHEA) 10%/Testosterone 0.5% Topical Gel is a compounded medication designed to deliver a combination of hormones directly through the skin. DHEA is a naturally occurring hormone that serves as a precursor to testosterone and other sex hormones. The inclusion of testosterone in this formulation aims to address deficiencies or imbalances of this specific hormone. The gel is compounded in a semisolid base that allows for a controlled and targeted application to the skin, ensuring consistent dosing and absorption. The pump mechanism of the container dispenses a measured dose of the gel, which can be applied to areas recommended by a healthcare provider, typically on areas with thin skin for optimal absorption, such as the inner arms or thighs.
This compounded formulation is primarily used in the treatment of conditions related to hormone deficiencies or imbalances, such as androgen deficiency, certain types of sexual dysfunction, and some menopausal symptoms. DHEA may help to improve mood, energy levels, and sexual function, while testosterone can be essential in maintaining muscle mass, bone density, and sexual health. The combination of DHEA and testosterone in a topical gel allows for the hormones to be absorbed directly into the bloodstream, bypassing the gastrointestinal tract and potentially reducing the risk of systemic side effects.
It is important for patients and prescribers to understand that the use of this compounded formulation should be based on a thorough evaluation of the patient's hormonal profile and clinical symptoms. Monitoring of hormone levels and adjustment of the dose may be necessary to achieve optimal therapeutic outcomes. Patients should be instructed on the proper application technique, including site rotation and cleanliness of the skin to prevent irritation or infection. Additionally, precautions should be taken to prevent the transfer of the gel to others, particularly women and children, as exposure to testosterone can have adverse effects.
As with any compounded medication, this formulation is prepared specifically for the individual patient in our state-of-the-art compounding facility at Bayview Pharmacy, ensuring the highest quality and safety standards. If you have any questions or require further information about the Dehydroepiandrosterone 10%/Testosterone 0.5% Topical Gel, or if you would like to discuss the suitability of this treatment for your patients, please do not hesitate to reach out to us. Our team of knowledgeable compounding pharmacists is here to provide support and guidance.
The Dehydroepiandrosterone (DHEA) 10%/Testosterone 0.5% Topical Gel is a hormone replacement therapy designed to address conditions associated with low or imbalanced hormone levels, such as certain endocrine disorders, menopausal symptoms, or testosterone deficiency in men. The gel is applied topically, allowing for direct absorption through the skin. It is important to note that while this formulation can be beneficial for treating these conditions, it also has the potential to interact with other medications and substances.
Patients should be aware that the use of DHEA and testosterone may interact with anticoagulants such as warfarin, potentially increasing the risk of bleeding. Close monitoring of coagulation parameters and adjustment of anticoagulant dosage may be necessary. Additionally, both DHEA and testosterone can alter blood glucose levels, which may necessitate adjustments in insulin or oral diabetes medication for patients with diabetes.
Concurrent use of corticosteroids or adrenocorticotropic hormone (ACTH) with this gel may result in altered effects of either the steroid therapy or the DHEA/testosterone treatment due to hormonal interactions. Patients using thyroid hormone replacement therapy should also be monitored, as androgens may decrease serum thyroxine-binding globulin (TBG) levels, leading to reduced total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction.
Testosterone is known to interact with cyclosporine, potentially leading to increased serum concentrations of the immunosuppressant and an increased risk of its toxic effects. The hepatic metabolism of certain drugs may be affected by testosterone, which could alter the effects of medications such as oxyphenbutazone. Additionally, patients should be cautious about using over-the-counter medications, herbal supplements, or other hormonal therapies concurrently with this gel without consulting a healthcare provider.
It is also important to consider the potential for androgenic side effects, which may be exacerbated when testosterone is used in combination with other androgenic agents. Patients should be advised to report any signs of virilization, such as deepening of the voice, acne, or menstrual irregularities. Furthermore, the use of DHEA and testosterone may influence the action of certain laboratory tests. Informing the healthcare provider about the use of this topical gel is crucial before undergoing lab tests.
Patients should be instructed to inform their healthcare providers of all medications, supplements, and herbal products they are currently taking before starting treatment with DHEA 10%/Testosterone 0.5% Topical Gel. This will help to avoid potential drug interactions and ensure safe and appropriate use of the hormone therapy. If you have any questions or require further information regarding drug interactions with this formulation, please reach out to us at Bayview Pharmacy for assistance.
The Dehydroepiandrosterone (DHEA) 10%/Testosterone 0.5% Topical Gel is a compounded medication designed to deliver hormones directly through the skin into the bloodstream. This semisolid formulation is dispensed through a pump mechanism, which ensures a consistent and precise dose with each application. The gel base is specifically chosen for its ability to facilitate the absorption of the active ingredients, DHEA and Testosterone, through the skin barrier.
DHEA is a naturally occurring hormone produced by the adrenal glands, which serves as a precursor to testosterone and other sex hormones. As people age, DHEA levels naturally decline, which can lead to a decrease in the formation of androgens and estrogens. Supplementing with DHEA can help restore hormonal balance, improve energy levels, and support overall well-being. Testosterone, another key hormone, plays a critical role in muscle strength, bone density, and sexual function. The combination of DHEA and Testosterone in this topical gel aims to address deficiencies or imbalances in these hormones.
The gel is applied to the skin, where it is absorbed into the underlying tissue and enters the bloodstream. This route of administration bypasses the gastrointestinal tract, reducing the potential for metabolic breakdown of the hormones before they reach the systemic circulation. This can lead to more stable blood levels and may reduce the risk of certain side effects associated with oral administration.
This compounded formulation is often used in the treatment of conditions such as androgen deficiency, certain types of sexual dysfunction, and some of the symptoms associated with menopause or aging in both men and women. By restoring hormonal balance, patients may experience improvements in energy, mood, libido, muscle mass, and bone density. It is important to note that hormone replacement therapy should be tailored to the individual's needs and monitored by a healthcare provider to ensure safety and efficacy.
For patients and prescribers considering this formulation, it is essential to understand that the use of compounded hormone therapies should be based on a thorough evaluation of the patient's hormonal status and clinical presentation. Regular follow-up and laboratory assessments are recommended to adjust dosing and to monitor the treatment's effectiveness and safety. If you have any questions or require further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support for your specific healthcare needs.
Dehydroepiandrosterone (DHEA) 10%/Testosterone 0.5% Topical Gel is a hormone replacement therapy designed to deliver specific doses of the hormones DHEA and testosterone through the skin. It is typically used to treat hormonal imbalances, such as those that can occur during menopause or andropause, or in certain medical conditions that cause hormone deficiencies.
Apply the gel as directed by your healthcare provider. The semisolid formulation is dispensed through a pump mechanism to facilitate easy and precise application. Gently spread the gel on the skin, focusing on the absorption areas recommended by your doctor, typically on areas like the arms, shoulders, or abdomen.
The pump is designed to deliver a measured dose of gel with each actuation. Before first use, you may need to prime the pump by pressing it several times until the gel begins to dispense. After priming, the pump should release a consistent dose with each press. Your healthcare provider will instruct you on the number of pumps needed per application.
No, you should only apply the gel to areas as instructed by your healthcare provider. Common application sites include the arms, shoulders, or abdomen, but not the genital areas. Applying it to other areas can alter the absorption or increase the risk of side effects.
If you miss a dose, apply it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
As with any medication, there may be potential side effects. These can include skin irritation at the application site, changes in hair growth, increased acne, changes in libido, and mood swings. Contact your healthcare provider if any of these side effects become severe or if you experience any unusual symptoms.
Store the gel at room temperature, away from heat and direct sunlight. Do not freeze it. Keep the container tightly closed when not in use. Make sure to keep the medication out of reach of children and pets.
Yes, but make sure to allow enough time for the gel to dry completely before engaging in such activities. This typically means waiting 5 to 6 hours after application. This helps ensure that the hormones are properly absorbed into your skin.
There is a risk of transferring the gel to others if skin-to-skin contact occurs at the application site. To minimize this risk, cover the application site with clothing after the gel has dried, and wash your hands thoroughly with soap and water after applying the gel.
Not everyone should use this hormone therapy. It's specifically prescribed by healthcare providers for individuals with hormonal deficiencies or imbalances. It should not be used by individuals with hormone-sensitive cancers, pregnant or breastfeeding women, or those with certain medical conditions. Always consult with a healthcare provider before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)